These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22433804)

  • 61. Long-term outcome of the use of botulinum toxin injection for functional anal pain.
    Hollingshead JR; Maeda Y; Brown TJ; Warusavitarne J; Vaizey CJ
    Colorectal Dis; 2011 Sep; 13(9):e293-6. PubMed ID: 21689353
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Pain syndrome in patients with spastic torticollis before and after the treatment with dysport].
    Zalialova ZA; Abdulgalimova DM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 2):62-5. PubMed ID: 21389941
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of botulinum toxin A therapy with electrical stimulation on spastic calf muscles in children with cerebral palsy.
    Kang BS; Bang MS; Jung SH
    Am J Phys Med Rehabil; 2007 Nov; 86(11):901-6. PubMed ID: 17873826
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Gamma knife thalamotomy for disabling tremor: a blinded evaluation.
    Lim SY; Hodaie M; Fallis M; Poon YY; Mazzella F; Moro E
    Arch Neurol; 2010 May; 67(5):584-8. PubMed ID: 20457958
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary axillary hyperhidrosis: a study in 83 patients.
    Lecouflet M; Leux C; Fenot M; Célerier P; Maillard H
    J Am Acad Dermatol; 2013 Dec; 69(6):960-4. PubMed ID: 24035554
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of short-term electrical stimulation before and after botulinum toxin injection.
    Santus G; Faletti S; Bordanzi I; Pirali F; De Grandis D
    J Rehabil Med; 2011 Apr; 43(5):420-3. PubMed ID: 21448556
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Botulinum toxin in the treatment of post-radiosurgical neck contracture in head and neck cancer: a novel approach.
    Bach CA; Wagner I; Lachiver X; Baujat B; Chabolle F
    Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Feb; 129(1):6-10. PubMed ID: 22104582
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?
    Benecke R; Heinze A; Reichel G; Hefter H; Göbel H;
    Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Superior rectus underaction following botulinum toxin injection to induce protective upper eye lid ptosis--a comparative study of two techniques.
    Sadiq SA; Dharmasena A
    Strabismus; 2014 Sep; 22(3):111-4. PubMed ID: 25005249
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
    Vergilis-Kalner IJ
    J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity.
    Suputtitada A; Suwanwela NC
    Disabil Rehabil; 2005 Feb; 27(4):176-84. PubMed ID: 15824048
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Early pain reduction in the treatment of spasticity after a single injection of botulinum A toxin].
    Chalkiadaki A; Rohr UP; Hefter H
    Dtsch Med Wochenschr; 2001 Nov; 126(48):1361-4. PubMed ID: 11727162
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Use of botulinum neurotoxin therapy].
    Mukai Y; Kaji R
    Brain Nerve; 2011 Jul; 63(7):775-84. PubMed ID: 21747148
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy and safety of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity: results of the German-Austrian open-label post-marketing surveillance prospective study.
    Jost WH; Hefter H; Reissig A; Kollewe K; Wissel J
    J Neurol Sci; 2014 Feb; 337(1-2):86-90. PubMed ID: 24361062
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections: a randomized controlled study.
    Gassner HG; Sherris DA
    Mayo Clin Proc; 2000 Jul; 75(7):701-4. PubMed ID: 10907385
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Current and Future Neuropharmacological Options for the Treatment of Essential Tremor.
    Alonso-Navarro H; García-Martín E; Agúndez JAG; Jiménez-Jiménez FJ
    Curr Neuropharmacol; 2020; 18(6):518-537. PubMed ID: 31976837
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Botulinum toxin for the treatment of tremor.
    Mittal SO; Pandey S
    J Neurol Sci; 2022 Apr; 435():120203. PubMed ID: 35227926
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Current and Emerging Treatments of Essential Tremor.
    Ondo WG
    Neurol Clin; 2020 May; 38(2):309-323. PubMed ID: 32279712
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Voice Tremor and Botulinum Neurotoxin Therapy: A Contemporary Review.
    Newland DP; Novakovic D; Richards AL
    Toxins (Basel); 2022 Nov; 14(11):. PubMed ID: 36356023
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Unawareness of head tremor in essential tremor: a study of three samples of essential tremor patients.
    Louis ED; Pellegrino KM; Rios E
    Mov Disord; 2008 Dec; 23(16):2423-4. PubMed ID: 18831531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.